Katja Horvat is a Master student of Biotechnology at the Biotechnical Faculty, University of Ljubljana. In collaboration with the Faculty of Pharmacy and the Faculty of Medicine she has performed gene expression analysis of patients with coronary artery disease, the results of which were published in the scientific article in Journal of Cardiovascular Development and Disease. She is currently part of the research group investigating osteoporosis during her traineeship at University of Turku. She has also gained experience in an industrial environment at the company Lek d.d., Novartis first in the Regulatory department and later in the production of Biopharmaceuticals. In her free time she enjoys spending time in nature and doing different sports. Sometimes she also likes to volunteer at bigger sports events.